All In MedTech

Device Trial Radar · NCT07933094

Combined TECAR/EMS Therapy vs. Standard Manual Therapy for Endometriosis Pelvic Pain

Comparative Effects of Combined TECAR Radiofrequency and Electrical Muscle Stimulation Therapy Versus Standard Manual Therapy for Pelvic Pain in Women With Endometriosis

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

72

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Mar 2027

Study completion Mar 2027

Sponsor

Lead sponsor
SWIMS America Corp.Not on our public-company list
Sponsor type
Industry
First posted
Nov 12, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study compares two ways of delivering a combined radiofrequency (RET), muscle stimulation (Hi-EMS), and pulsed radiofrequency (Hi-TENS) therapy, hands-on by a physical therapist or hands-free using adhesive pads, and compares the combined therapy to hands-on manual therapy alone for pelvic pain in women with endometriosis. Participants attend 8 sessions over 6 weeks.

Conditions

  • Endometriosis
  • Pelvic Pain

Interventions

  • Winback BACK4 - hands-on TECAR+EMSDevice

    Winback BACK4 combined RET/Hi-EMS/Hi-TENS delivered hands-on by the treating clinician (conductive electrode technique) together with manual therapy. 8 sessions over 6 weeks.

  • Winback BACK4 - hands-free Pelvic+Device

    Winback BACK4 combined RET/Hi-EMS/Hi-TENS delivered hands-free via adhesive electrode pads, with the clinician present for matched session time. 8 sessions over 6 weeks.

  • Hands-on manual pelvic floor physical therapyOther

    Standard-of-care hands-on manual pelvic floor physical therapy without the device, with matched session time. 8 sessions over 6 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in pelvic pain, 0-10 Visual Analog Scale (VAS)Time frame: Baseline to study exit (6 weeks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Inspira Physical Therapy

    Brooklyn, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.